












Li-Yao Huang
Founder at FinalDose
Founder at FinalDose (YC P26). DPhil in Biochemistry from Oxford, where he spent 5 years as a postdoctoral researcher at the MRC Weatherall Institute of Molecular Medicine. Led CRISPR screening projects uncovering new druggable targets in cancer cells and built pipelines reducing hit validation time from months to 7 days. Research focuses on BRCA1-deficient cancers and PARP inhibitor resistance mechanisms.
Follow Li-Yao
Previously at

MRC Weatherall Institute of Molecular Medicine

The Department of Biochemistry, University of Oxford
Alumnus of

University of Oxford

National Cheng Kung University

National Yang Ming Chiao Tung University